| ISIN | LU1048648130 |
|---|---|
| Valor Number | 25008424 |
| Bloomberg Global ID | |
| Fund Name | Swiss Rock Aktien Europa X |
| Fund Provider |
Swiss Rock Asset Management AG
Zürich, Switzerland Phone: +41 44 360 57 00 E-Mail: info@swiss-rock.ch Web: www.swiss-rock.ch |
| Fund Provider | Swiss Rock Asset Management AG |
| Representative in Switzerland |
Swiss Rock Asset Management AG Zürich Phone: +41 44 360 57 00 |
| Distributor(s) |
Swiss Rock Asset Management AG Zürich Phone: +41 44 360 57 00 |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund management company and/or distributor charges a redemption commission (different commissions can be charged for the same fund depending on the sales channel) |
| Investment Strategy *** | Top tier performance in european equity with a rock solid investment approach, rotating investment styles. |
| Peculiarities |
| Current Price * | 24.57 EUR | 17.11.2025 |
|---|---|---|
| Previous Price * | 24.70 EUR | 14.11.2025 |
| 52 Week High * | 25.09 EUR | 12.11.2025 |
| 52 Week Low * | 19.74 EUR | 09.04.2025 |
| NAV * | 24.57 EUR | 17.11.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 50,380,867 | |
| Unit/Share Assets *** | 1,714,686 | |
| Trading Information SIX | ||
| YTD Performance | +17.22% |
31.12.2024 - 17.11.2025
31.12.2024 17.11.2025 |
|---|---|---|
| YTD Performance (in CHF) | +15.06% |
31.12.2024 - 17.11.2025
31.12.2024 17.11.2025 |
| 1 month | +1.70% |
17.10.2025 - 17.11.2025
17.10.2025 17.11.2025 |
| 3 months | +3.63% |
18.08.2025 - 17.11.2025
18.08.2025 17.11.2025 |
| 6 months | +4.69% |
19.05.2025 - 17.11.2025
19.05.2025 17.11.2025 |
| 1 year | +18.07% |
18.11.2024 - 17.11.2025
18.11.2024 17.11.2025 |
| 2 years | +38.27% |
17.11.2023 - 17.11.2025
17.11.2023 17.11.2025 |
| 3 years | +53.85% |
17.11.2022 - 17.11.2025
17.11.2022 17.11.2025 |
| 5 years | +80.00% |
17.11.2020 - 17.11.2025
17.11.2020 17.11.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SAP SE | 3.14% | |
|---|---|---|
| Novartis AG Registered Shares | 2.76% | |
| ASML Holding NV | 2.66% | |
| Novo Nordisk AS Class B | 1.97% | |
| HSBC Holdings PLC | 1.97% | |
| Siemens AG | 1.96% | |
| Allianz SE | 1.53% | |
| Schneider Electric SE | 1.42% | |
| AstraZeneca PLC | 1.41% | |
| Roche Holding AG | 1.35% | |
| Last data update | 30.06.2025 | |
| TER *** | 0.27% |
|---|---|
| TER date *** | 30.06.2025 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | |
| Ongoing Charges *** | 0.28% |
|
SRRI ***
|
|
| SRRI date *** | 31.10.2025 |